Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, Bishop DT, Weber B, Lenoir G, Chang-Claude J, et al: Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet. 1998, 62: 676-689. 10.1086/301749.
Article
CAS
PubMed
PubMed Central
Google Scholar
Moll UM, Riou G, Levine AJ: Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion. Proc Natl Acad Sci USA. 1992, 89: 7262-7266.
Article
CAS
PubMed
PubMed Central
Google Scholar
Shugart YY, Cour C, Renard H, Lenoir G, Goldgar D, Teare D, Easton D, Rahman N, Gusterton R, Seal S, et al: Linkage analysis of 56 multiplex families excludes the Cowden disease gene PTEN as a major contributor to familial breast cancer. J Med Genet. 1999, 36: 720-721.
CAS
PubMed
PubMed Central
Google Scholar
Chenevix-Trench G, Spurdle AB, Gatei M, Kelly H, Marsh A, Chen X, Donn K, Cummings M, Nyholt D, Jenkins MA, et al: Dominant negative ATM mutations in breast cancer families. J Natl Cancer Inst. 2002, 94: 205-215.
Article
PubMed
Google Scholar
Meijers-Heijboer H, van den Ouweland A, Klijn J, Wasielewski M, de Snoo A, Oldenburg R, Hollestelle A, Houben M, Crepin E, van Veghel-Plandsoen M, et al: Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat Genet. 2002, 31: 55-59. 10.1038/ng879.
Article
CAS
PubMed
Google Scholar
Meetei AR, de Winter JP, Medhurst AL, Wallisch M, Waisfisz Q, van de Vrugt HJ, Oostra AB, Yan Z, Ling C, Bishop CE, et al: A novel ubiquitin ligase is deficient in Fanconi anemia. Nat Genet. 2003, 35: 165-170. 10.1038/ng1241.
Article
CAS
PubMed
Google Scholar
Bagby GC: Genetic basis of Fanconi anemia. Curr Opin Hematol. 2003, 10: 68-76. 10.1097/00062752-200301000-00011.
Article
CAS
PubMed
Google Scholar
Grompe M, D'Andrea A: Fanconi anemia and DNA repair. Hum Mol Genet. 2001, 10: 2253-2259. 10.1093/hmg/10.20.2253.
Article
CAS
PubMed
Google Scholar
D'Andrea AD, Grompe M: The Fanconi anaemia/BRCA pathway. Nat Rev Cancer. 2003, 3: 23-34. 10.1038/nrc970.
Article
PubMed
Google Scholar
Houghtaling S, Timmers C, Noll M, Finegold MJ, Jones SN, Meyn MS, Grompe M: Epithelial cancer in Fanconi anemia complementation group D2 (Fancd2) knockout mice. Genes Dev. 2003, 17: 2021-2035. 10.1101/gad.1103403.
Article
CAS
PubMed
PubMed Central
Google Scholar
McAllister KA, Bennett LM, Houle CD, Ward T, Malphurs J, Collins NK, Cachafeiro C, Haseman J, Goulding EH, Bunch D, et al: Cancer susceptibility of mice with a homozygous deletion in the COOH-terminal domain of the Brca2 gene. Cancer Res. 2002, 62: 990-994.
CAS
PubMed
Google Scholar
Taniguchi T, Tischkowitz M, Ameziane N, Hodgson SV, Mathew CG, Joenje H, Mok SC, D'Andrea AD: Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumours. Nat Med. 2003, 9: 568-574. 10.1038/nm852.
Article
CAS
PubMed
Google Scholar
Lounis H, Mes-Masson AM, Dion F, Bradley WE, Seymour RJ, Provencher D, Tonin PN: Mapping of chromosome 3p deletions in human epithelial ovarian tumours. Oncogene. 1998, 17: 2359-2365. 10.1038/sj.onc.1202152.
Article
CAS
PubMed
Google Scholar
Seal S, Barfoot R, Jayatilake H, Smith P, Renwick A, Bascombe L, McGuffog L, Evans DG, Eccles D, Easton DF, et al: Evaluation of Fanconi Anemia genes in familial breast cancer predisposition. Cancer Res. 2003, 63: 8596-8599.
CAS
PubMed
Google Scholar
Cantor SB, Bell DW, Ganesan S, Kass EM, Drapkin R, Grossman S, Wahrer DC, Sgroi DC, Lane WS, Haber DA, et al: BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function. Cell. 2001, 105: 149-160. 10.1016/S0092-8674(01)00304-X.
Article
CAS
PubMed
Google Scholar
Karppinen SM, Vuosku J, Heikkinen K, Allinen M, Winqvist R: No evidence of involvement of germline BACH1 mutations in Finnish breast and ovarian cancer families. Eur J Cancer. 2003, 39: 366-371. 10.1016/S0959-8049(02)00498-7.
Article
CAS
PubMed
Google Scholar
Rutter JL, Smith AM, Davila MR, Sigurdson AJ, Giusti RM, Pineda MA, Doody MM, Tucker MA, Greene MH, Zhang J, et al: Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals. Hum Mutat. 2003, 22: 121-128. 10.1002/humu.10238.
Article
CAS
PubMed
Google Scholar
Rabbitts TH: LMO T-cell translocation oncogenes typify genes activated by chromosomal translocations that alter transcription and developmental processes. Genes Dev. 1998, 12: 2651-2657.
Article
CAS
PubMed
Google Scholar
Visvader JE, Venter D, Hahm K, Santamaria M, Sum EY, O'Reilly L, White D, Williams R, Armes J, Lindeman GJ: The LIM domain gene LMO4 inhibits differentiation of mammary epithelial cells in vitro and is overexpressed in breast cancer. Proc Natl Acad Sci USA. 2001, 98: 14452-14457. 10.1073/pnas.251547698.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sum EY, Segara D, Duscio B, Bath ML, Field AS, Sutherland RL, Lindeman GJ, Visvader JE: Overexpression of LMO4 induces mammary hyperplasia, promotes cell invasion, and is a predictor of poor outcome in breast cancer. Proc Natl Acad Sci USA. 2005, 102: 7659-7664. 10.1073/pnas.0502990102.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sum EY, Peng B, Yu X, Chen J, Byrne J, Lindeman GJ, Visvader JE: The LIM domain protein LMO4 interacts with the cofactor CtIP and the tumour suppressor BRCA1 and inhibits BRCA1 activity. J Biol Chem. 2002, 277: 7849-7856. 10.1074/jbc.M110603200.
Article
CAS
PubMed
Google Scholar
Sutherland KD, Visvader JE, Choong DY, Sum EY, Lindeman GJ, Campbell IG: Mutational analysis of the LMO4 gene, encoding a BRCA1-interacting protein, in breast carcinomas. Int J Cancer. 2003, 107: 155-158. 10.1002/ijc.11343.
Article
CAS
PubMed
Google Scholar
Prasad GL, Valverius EM, McDuffie E, Cooper HL: Complementary DNA cloning of a novel epithelial cell marker protein, HME1, that may be down-regulated in neoplastic mammary cells. Cell Growth Differ. 1992, 3: 507-513.
CAS
PubMed
Google Scholar
Ferguson AT, Evron E, Umbricht CB, Pandita TK, Chan TA, Hermeking H, Marks JR, Lambers AR, Futreal PA, Stampfer MR, et al: High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer. Proc Natl Acad Sci USA. 2000, 97: 6049-6054. 10.1073/pnas.100566997.
Article
CAS
PubMed
PubMed Central
Google Scholar
Umbricht CB, Evron E, Gabrielson E, Ferguson A, Marks J, Sukumar S: Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer. Oncogene. 2001, 20: 3348-3353. 10.1038/sj.onc.1204438.
Article
CAS
PubMed
Google Scholar
Laronga C, Yang HY, Neal C, Lee MH: Association of the cyclin-dependent kinases and 14-3-3 sigma negatively regulates cell cycle progression. J Biol Chem. 2000, 275: 23106-23112. 10.1074/jbc.M905616199.
Article
CAS
PubMed
Google Scholar
Aprelikova O, Pace AJ, Fang B, Koller BH, Liu ET: BRCA1 is a selective co-activator of 14-3-3 sigma gene transcription in mouse embryonic stem cells. J Biol Chem. 2001, 276: 25647-25650. 10.1074/jbc.C100265200.
Article
CAS
PubMed
Google Scholar
van 't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, et al: Gene expression profiling predicts clinical outcome of breast cancer. Nature. 2002, 415: 530-536. 10.1038/415530a.
Article
PubMed
Google Scholar
Borg A, Zhang QX, Olsson H, Wenngren E: Chromosome 1 alterations in breast cancer: allelic loss on 1p and 1q is related to lymphogenic metastases and poor prognosis. Genes Chromosomes Cancer. 1992, 5: 311-320.
Article
CAS
PubMed
Google Scholar
Tsukamoto K, Ito N, Yoshimoto M, Kasumi F, Akiyama F, Sakamoto G, Nakamura Y, Emi M: Allelic loss on chromosome 1p is associated with progression and lymph node metastasis of primary breast carcinoma. Cancer. 1998, 82: 317-322. 10.1002/(SICI)1097-0142(19980115)82:2<323::AID-CNCR11>3.0.CO;2-0.
Article
CAS
PubMed
Google Scholar
Millikan RC, Ingles SA, Diep AT, Xue S, Zhou N, Florentine BD, Sparkes RS, Haile RW: Linkage analysis and loss of heterozygosity for chromosome arm 1p in familial breast cancer. Genes Chromosomes Cancer. 1999, 25: 354-361. 10.1002/(SICI)1098-2264(199908)25:4<354::AID-GCC7>3.0.CO;2-O.
Article
CAS
PubMed
Google Scholar
Osborne RH, Hopper JL, Kirk JA, Chenevix-Trench G, Thorne HJ, Sambrook JF: kConFab: a research resource of Australasian breast cancer families. Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer [letter]. Med J Aust. 2000, 172: 463-464.
CAS
PubMed
Google Scholar
Rozen S, Skaletsky H: Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol. 2000, 132: 365-386.
CAS
PubMed
Google Scholar
Jones AC, Austin J, Hansen N, Hoogendoorn B, Oefner PJ, Cheadle JP, O'Donovan MC: Optimal temperature selection for mutation detection by denaturing HPLC and comparison to single-stranded conformation polymorphism and heteroduplex analysis. Clin Chem. 1999, 45: 1133-1140.
CAS
PubMed
Google Scholar
Spiegelman JI, Mindrinos MN, Oefner PJ: High-accuracy DNA sequence variation screening by DHPLC. Biotechniques. 2000, 29: 1084-1090. 1092
CAS
PubMed
Google Scholar
Karolchik D, Baertsch R, Diekhans M, Furey TS, Hinrichs A, Lu YT, Roskin KM, Schwartz M, Sugnet CW, Thomas DJ, et al: The UCSC Genome Browser Database. Nucleic Acids Res. 2003, 31: 51-54. 10.1093/nar/gkg129.
Article
CAS
PubMed
PubMed Central
Google Scholar
Reese MG, Eeckman FH, Kulp D, Haussler D: Improved splice site detection in Genie. J Comput Biol. 1997, 4: 311-323.
Article
CAS
PubMed
Google Scholar
Cartegni L, Wang J, Zhu Z, Zhang MQ, Krainer AR: ESEfinder: A web resource to identify exonic splicing enhancers. Nucleic Acids Res. 2003, 31: 3568-3571. 10.1093/nar/gkg616.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zuker M: Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res. 2003, 31: 3406-3415. 10.1093/nar/gkg595.
Article
CAS
PubMed
PubMed Central
Google Scholar
Frueh FW, Noyer-Weidner M: The use of denaturing high-performance liquid chromatography (DHPLC) for the analysis of genetic variations: impact for diagnostics and pharmacogenetics. Clin Chem Lab Med. 2003, 41: 452-461. 10.1515/CCLM.2003.068.
Article
CAS
PubMed
Google Scholar
SpliceSiteFinder. [http://www.genet.sickkids.on.ca/~ali/splicesitefinder.html]
NCBI. [http://www.ncbi.nlm.nih.gov/]
Celera. [http://www.celera.com/]
SNPper. [http://snpper.chip.org/bio/]
Fanconi Anemia Mutation Database. [http://www.rockefeller.edu/fanconi/mutate/]